Inflammatory Proteins Mediate the Effect of Gut Microbiota on Graves' Ophthalmopathy: A Mendelian Randomization Study.

PURPOSE: This study investigates the causal relationship between gut microbiota (GM) and Graves' ophthalmopathy (GO) and explores the mediating role of circulating inflammatory proteins (IPs) in this association.

METHODS

A two-step, two-sample Mendelian randomization (MR) analysis was performed using GM data from MiBioGen (N = 18,340), GO data from the FinnGen Research Project (691 cases, 411,490 controls), and IP data from a genome-wide association study (N = 14,824). The primary MR analysis utilized the inverse variance-weighted approach, supplemented by MR Egger, weighted median, maximum likelihood, and MR robust adjusted profile score methods. Mediation MR was used to assess the mediating role of IPs.

RESULTS

We identified 26 GM taxa causally associated with GO. Notably, the genus Parabacteroides exhibited a protective effect on GO (odds ratio = 0.29; 95% confidence interval, 0.16-0.51; P < 0.001). Additionally, five circulating IPs demonstrated protective effects, while three IPs (CXCL10, CXCL11, EN-RAGE) were associated with increased GO risk. Mediation MR showed that CXCL10 mediated the pathway from Parabacteroides to GO (mediation effect = -0.07), accounting for 5.27% of the total effect.

CONCLUSIONS

This study supports a causal link between GM and GO, mediated by circulating IPs. These findings offer new insights into GO pathogenesis and potential targets for clinical intervention.

TRANSLATIONAL RELEVANCE: Our findings reveal how gut microbiota influences Graves' ophthalmopathy through inflammatory proteins, providing potential therapeutic targets for disease prevention and treatment.